Further clinical studies within the ADNI database have shown that in females with mild cognitive impairment, increased uricemia may interact with apolipoprotein E4 (APOE4) to alleviate longitudinal metabolic changes and cognitive decline. The gene discussed is APOE; the disease is Cognitive impairment.